siRNA therapy reduces triglycerides in individuals along with unusual problem
.RESEARCH STUDY HIGHLIGHT.19 September 2024.
Plozasiran reduced triglyceride amounts through 80% and decreased the risk of pancreatitis in clients along with relentless chylomicronemia, along with or without a genetic prognosis.